• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2024

    12/4/24 4:05:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SNPS alert in real time by email

    Results Summary1 

    • Record quarterly revenue of $1.636 billion, up approximately 11% year over year (YoY), exceeding the mid-point of guidance.
    • Quarterly GAAP earnings per diluted share (EPS) of $1.79; non-GAAP EPS of $3.40, up approximately 13% YoY, exceeding guidance.
    • Achieved record full-year 2024 revenue of $6.127 billion, up approximately 15% YoY, while improving non-GAAP operating margin and delivering approximately 25% non-GAAP EPS growth.
    • Expecting to deliver double digit revenue growth in 2025 while preparing for Ansys acquisition close, which remains on-track for the first half of 2025.

    SUNNYVALE, Calif., Dec. 4, 2024 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its fourth quarter and fiscal year 2024. Revenue for the fourth quarter of fiscal year 2024 was $1.636 billion, compared to $1.467 billion for the fourth quarter of fiscal year 2023. Revenue for fiscal year 2024 was $6.127 billion, an increase of approximately 15% from $5.318 billion in fiscal year 2023.

    Synopsys headquarters in Sunnyvale, Calif. (PRNewsfoto/Synopsys, Inc.)

    "The fourth quarter was a strong finish to a transformational year for Synopsys. We achieved record financial results while doubling down on our strategy with the sale of our Software Integrity business and the pending acquisition of Ansys," said Sassine Ghazi, president and CEO of Synopsys. "Looking ahead, the AI-driven reinvention of compute is accelerating the pace, scale and complexity of technology R&D, which expands our opportunity to solve engineering challenges from silicon to systems."

    "Continued strong execution drove excellent Q4 results, which exceeded the midpoint of our guidance targets and capped a year of 15% revenue growth for the company," said Shelagh Glaser, CFO of Synopsys. "The combination of our execution focus, operating discipline, and the critical nature of our industry-leading technology positions us well for the future. In 2025, we expect to deliver double-digit revenue growth grounded in pragmatism given continued macro uncertainties and the impact of our fiscal year calendar change."

    Synopsys' previously announced acquisition of Ansys is expected to close in the first half of 2025, subject to the receipt of required regulatory approvals and other customary closing conditions. This week marked the expiration of the Hart-Scott-Rodino (HSR) Act waiting period, and Synopsys is working cooperatively with Federal Trade Commission (FTC) staff to conclude the investigation and the staff's review of Synopsys' proposed remedies.

    _______________________________________________

    1 On September 30, 2024, Synopsys completed the sale of its Software Integrity business. Synopsys' Software Integrity business has been presented as a discontinued operation in the consolidated financial statements for all periods presented herein and all financial results and targets are presented herein on a continuing operations basis unless otherwise noted.

    Continuing Operations

    On September 30, 2024, Synopsys completed the sale of its Software Integrity business. Unless otherwise noted, Synopsys' Software Integrity business has been presented as a discontinued operation in the Synopsys' consolidated financial statements for all periods presented herein and all financial results and targets are presented herein on a continuing operations basis.

    GAAP Results

    On a U.S. generally accepted accounting principles (GAAP) basis, net income for the fourth quarter of fiscal year 2024 was $279.3 million, or $1.79 per diluted share, compared to $346.1 million, or $2.23 per diluted share, for the fourth quarter of fiscal year 2023. GAAP net income for fiscal year 2024 was $1.442 billion, or $9.25 per diluted share, compared to $1.227 billion, or $7.91 per diluted share, for fiscal year 2023.

    Non-GAAP Results

    On a non-GAAP basis, net income for the fourth quarter of fiscal year 2024 was $529.9 million, or $3.40 per diluted share, compared to non-GAAP net income of $464.1 million, or $3.00 per diluted share, for the fourth quarter of fiscal year 2023. Non-GAAP net income for fiscal year 2024 was $2.058 billion, or $13.20 per diluted share, compared to non-GAAP net income of $1.636 billion, or $10.54 per diluted share, for fiscal year 2023.

    For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below. 

    Business Segments 

    Synopsys reports revenue and operating income in two segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and field programmable gate array IC design software, verification software and hardware products, manufacturing software products and other and (2) Design IP, which includes our interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services.

    Financial Targets 

    Synopsys also provided its consolidated financial targets for the first quarter and full fiscal year 2025. These targets reflect a change in Synopsys' fiscal year from a 52/53-week period ending on the Saturday nearest to October 31 of each year to October 31 of each year. As a result of this change, there will be ten fewer days in the first half of fiscal year 2025 and two extra days in the second half of fiscal year 2025, which results in eight fewer days in the aggregate in Synopsys' fiscal year 2025 as compared to its fiscal year 2024. These targets also assume no further changes to export control restrictions or the current U.S. government "Entity List" restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see "Forward-Looking Statements" below. 

    First Quarter and Full Fiscal Year 2025 Financial Targets (1)

    (in millions except per share amounts)















    Range for Three Months Ending



    Range for Fiscal Year Ending



    January 31, 2025



    October 31, 2025



    Low

    High



    Low

    High

    Revenue

    $              1,435

    $              1,465



    $              6,745

    $              6,805

    GAAP Expenses

    $              1,142

    $              1,162



    $              4,926

    $              4,983

    Non-GAAP Expenses

    $                 945

    $                 955



    $              4,045

    $              4,085

    Non-GAAP Interest and Other Income (Expense), net

    $                   20

    $                   22



    $                   94

    $                   98

    Non-GAAP Tax Rate

    16 %

    16 %



    16 %

    16 %

    Outstanding Shares (fully diluted)

    156

    158



    157

    159

    GAAP EPS

    $                1.81

    $                1.95



    $              10.42

    $              10.63

    Non-GAAP EPS

    $                2.77

    $                2.82



    $              14.88

    $              14.96

    Operating Cash Flow







    ~ $1,800

    Free Cash Flow(2)







    ~ $1,600

    Capital Expenditures







    ~ $170













    (1) Synopsys' first quarter of fiscal year 2025 will end on January 31, 2025 and its fiscal year 2025 will end on October 31, 2025.

    (2) Free cash flow is calculated as cash provided from operating activities less capital expenditures.

    For a reconciliation of Synopsys' first quarter and fiscal year 2025 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis and a discussion of the financial targets that we are not able to reconcile without unreasonable efforts, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below. 

    Earnings Call Open to Investors

    Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys' corporate website at investor.synopsys.com. Synopsys uses its website as a tool to disclose important information about Synopsys and comply with its disclosure obligations under Regulation Fair Disclosure. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the first quarter of fiscal year 2025 in February 2025. 

    Effectiveness of Information

    The targets included in this press release, the statements made during the earnings conference call, the information contained in the financial supplement and the corporate overview presentation, each of which are available on Synopsys' corporate website at www.synopsys.com (collectively, the "Earnings Materials"), represent Synopsys' expectations and beliefs as of December 4, 2024. Although these Earnings Materials will remain available on Synopsys' website through the date of the earnings call for the first quarter of fiscal year 2025, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

    Availability of Final Financial Statements

    Synopsys will include final financial statements for the fiscal year 2024 in its annual report on Form 10-K to be filed on or before January 2, 2025.

    About Synopsys

    Catalyzing the era of pervasive intelligence, Synopsys, Inc. (NASDAQ:SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.

    Reconciliation of Fourth Quarter and Fiscal Year 2024 Results

    The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income, earnings per diluted share, and tax rate for the periods indicated below.

    GAAP to Non-GAAP Reconciliation of Fourth Quarter and Fiscal Year 2024 Results(1)

    (unaudited and in thousands, except per share amounts)













    Three Months Ended

    Twelve Months Ended



    October 31,

    October 31,



    2024

    2023

    2024

    2023

    GAAP net income from continuing operations attributed to Synopsys

    $         279,281

    $         346,051

    $      1,441,710

    $      1,227,045

    Adjustments:









    Amortization of acquired intangible assets

    54,258

    14,886

    104,220

    50,477

    Stock-based compensation

    165,116

    128,286

    656,632

    511,730

    Acquisition/divestiture related items

    62,428

    4,016

    172,638

    13,831

    Restructuring charges

    —

    (1,348)

    —

    53,091

    Gain on sale of strategic investments

    —

    —

    (55,077)

    —

    Tax settlement

    —

    —

    —

    (23,752)

    Tax adjustments

    (31,158)

    (27,753)

    (262,322)

    (196,471)

    Non-GAAP net income from continuing operations attributed to Synopsys

    $         529,925

    $         464,138

    $      2,057,801

    $      1,635,951

































    Three Months Ended

    Twelve Months Ended



    October 31,

    October 31,



    2024

    2023

    2024

    2023

    GAAP net income from continuing operations per diluted share attributed to Synopsys

    $               1.79

    $               2.23

    $                9.25

    $                7.91

    Adjustments:









    Amortization of acquired intangible assets

    0.35

    0.10

    0.67

    0.33

    Stock-based compensation

    1.06

    0.83

    4.21

    3.30

    Acquisition/divestiture related items

    0.40

    0.03

    1.11

    0.09

    Restructuring charges

    —

    (0.01)

    —

    0.34

    Gain on sale of strategic investments

    —

    —

    (0.35)

    —

    Tax settlement

    —

    —

    —

    (0.15)

    Tax adjustments

    (0.20)

    (0.18)

    (1.69)

    (1.28)

    Non-GAAP net income from continuing operations per diluted share attributed to Synopsys

    $               3.40

    $               3.00

    $             13.20

    $             10.54











    Shares used in computing net income per diluted share amounts:

    155,991

    154,845

    155,944

    155,195











    (1) Synopsys' fourth quarter of fiscal year 2024 and 2023 ended on November 2, 2024 and October 28, 2023, respectively. For presentation

    purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.





    GAAP to Non-GAAP Tax Rate Reconciliation (1)(2)

    (unaudited)







    Twelve Months Ended



    October 31, 2024





    GAAP effective tax rate

    6.6 %

    Stock-based compensation

    2.9 %

    Income tax adjustments (3)

    5.5 %

    Non-GAAP effective tax rate

    15.0 %





    (1) Synopsys' fiscal year 2024 ended on November 2, 2024. For presentation purposes, we refer to

    the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra

    week in the first quarter.

    (2) Presented on a continuing operations basis.

    (3) The adjustments are primarily related to the differences in the tax rate effect of certain

    deductions, such as the deduction for foreign-derived intangible income and credits.

    GAAP to Non-GAAP Reconciliation of 2025 Targets

    The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

    GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2025 Targets

    (in thousands, except per share amounts)













     Range for Three Months Ending



    January 31, 2025



    Low

    High

    Target GAAP expenses

    $           1,142,000

    $           1,162,000

    Adjustments:





          Amortization of acquired intangible assets

    (12,000)

    (15,000)

          Stock-based compensation

    (185,000)

    (192,000)

    Target non-GAAP expenses

    $              945,000

    $              955,000



















    Range for Three Months Ending



    January 31, 2025



    Low

    High

    Target GAAP earnings per diluted share attributed to Synopsys

    $                    1.81

    $                    1.95

    Adjustments:





          Amortization of acquired intangible assets

    0.10

    0.08

          Stock-based compensation

    1.22

    1.18

          Acquisition/divestiture related items (1)

    0.08

    0.06

          Tax adjustments

    (0.44)

    (0.45)

    Target non-GAAP earnings per diluted share attributed to Synopsys

    $                    2.77

    $                    2.82







    Shares used in non-GAAP calculation (midpoint of target range)

    157,000

    157,000













    GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2025 Targets

    (in thousands, except per share amounts)













    Range for Fiscal Year Ending



    October 31, 2025



    Low

    High

    Target GAAP expenses

    $           4,926,000

    $           4,983,000

    Adjustments:





          Amortization of acquired intangible assets

    (46,000)

    (51,000)

          Stock-based compensation

    (835,000)

    (847,000)

    Target non-GAAP expenses

    $           4,045,000

    $           4,085,000



















    Range for Fiscal Year Ending



    October 31, 2025



    Low

    High

    Target GAAP earnings per diluted share attributed to Synopsys

    $                  10.42

    $                  10.63

    Adjustments:





          Amortization of acquired intangible assets

    0.32

    0.29

          Stock-based compensation

    5.36

    5.28

          Acquisition/divestiture related items (1)

    0.29

    0.26

          Tax adjustments

    (1.51)

    (1.50)

    Target non-GAAP earnings per diluted share attributed to Synopsys

    $                  14.88

    $                  14.96







    Shares used in non-GAAP calculation (midpoint of target range)

    158,000

    158,000







    (1) Adjustments reflect certain contractually obligated financing fees and related amortization expenses, and do not fully

     reflect all potential adjustments for future periods for the reasons set forth in "GAAP to Non-GAAP Reconciliation" below.

    Forward-Looking Statements

    This press release and the investor conference call contain forward-looking statements, including, but not limited to, statements regarding short-term and long-term financial targets, expectations and objectives including, among others, our long-term financial objectives, which include the anticipated effects of our pending acquisition of ANSYS, Inc. (the Ansys Merger); business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence; planned acquisitions and their expected impact, including the Ansys Merger; the potential impact of the uncertain macroeconomic and geopolitical environment on our financial results; the expected impact of U.S. and foreign government trade restrictions and regulatory changes, including export control restrictions and tariffs on our financial results; customer license renewals and the expected realization and timing of our contracted but unsatisfied or partially unsatisfied performance obligations (backlog); planned dispositions and their expected impact; customer demand and market expansion for our products and our customers' products; our ability to successfully compete in the markets we serve; our planned product releases and capabilities; industry growth rates; software trends; planned stock repurchases; our expected tax rate; and the impact and result of pending legal, regulatory, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and geopolitical uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations; failure to complete the Ansys Merger on the terms described in our filings with the SEC, if at all; failure to obtain required governmental approvals related to the Ansys Merger or the imposition of conditions to such governmental approvals that may have an adverse effect on us; failure to realize the benefits expected from the Ansys Merger; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys' results is included in filings we make with the SEC from time to time, including in the sections entitled "Risk Factors" in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys' most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. Synopsys' financial results for its fourth quarter and fiscal year 2024 are not necessarily indicative of Synopsys' operating results for any future periods. The information provided herein is as of December 4, 2024. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

    SYNOPSYS, INC.

    Unaudited Consolidated Statements of Income (1)

    (in thousands, except per share amounts)



























    Three Months Ended



    Twelve Months Ended



    October 31,



    October 31,



    2024

    2023



    2024

    2023

    Revenue:











      Time-based products

    $                 834,375

    $                 780,725



    $              3,224,299

    $              3,016,256

      Upfront products

    520,939

    441,494



    1,802,222

    1,400,125

        Total products revenue

    1,355,314

    1,222,219



    5,026,521

    4,416,381

      Maintenance and service

    280,672

    245,164



    1,100,915

    901,633

          Total revenue

    1,635,986

    1,467,383



    6,127,436

    5,318,014

    Cost of revenue:











      Products

    216,485

    197,540



    770,238

    697,686

      Maintenance and service

    91,707

    76,043



    367,055

    287,876

      Amortization of acquired intangible assets

    66,831

    12,598



    107,996

    45,281

          Total cost of revenue

    375,023

    286,181



    1,245,289

    1,030,843

    Gross margin

    1,260,963

    1,181,202



    4,882,147

    4,287,171

    Operating expenses:











      Research and development

    554,818

    465,815



    2,082,360

    1,849,935

      Sales and marketing

    219,225

    186,953



    859,342

    724,934

      General and administrative

    172,032

    102,271



    568,496

    376,677

      Amortization of acquired intangible assets

    4,086

    3,346



    16,238

    9,295

      Restructuring charges

    —

    (1,348)



    —

    53,091

          Total operating expenses

    950,161

    757,037



    3,526,436

    3,013,932

    Operating income

    310,802

    424,165



    1,355,711

    1,273,239

    Interest and other income (expense), net

    12,077

    (20,400)



    158,147

    32,231

    Income before income taxes

    322,879

    403,765



    1,513,858

    1,305,470

    Provision (benefit) for income taxes

    62,084

    60,409



    99,718

    90,188

    Net income from continuing operations

    260,795

    343,356



    1,414,140

    1,215,282

    Income from discontinued operations, net of income taxes

    834,825

    3,139



    821,670

    2,843

    Net income

    1,095,620

    346,495



    2,235,810

    1,218,125

    Less: Net income (loss) attributed to non-controlling interest and

    redeemable non-controlling interest

    (18,486)

    (2,695)



    (27,570)

    (11,763)

    Net income attributed to Synopsys

    $              1,114,106

    $                 349,190



    $              2,263,380

    $              1,229,888













    Net income attributed to Synopsys











      Continuing operations

    $                 279,281

    $                 346,051



    $              1,441,710

    $              1,227,045

      Discontinued operations

    834,825

    3,139



    821,670

    2,843

      Net income

    $              1,114,106

    $                 349,190



    $              2,263,380

    $              1,229,888













    Net income per share attributed to Synopsys - basic:











      Continuing operations

    $                      1.81

    $                      2.28



    $                      9.41

    $                      8.06

      Discontinued operations

    5.43

    0.02



    5.37

    0.02

      Basic net income per share

    $                      7.24

    $                      2.30



    $                     14.78

    $                      8.08













    Net income per share attributed to Synopsys - diluted:











      Continuing operations

    $                      1.79

    $                      2.23



    $                      9.25

    $                      7.91

      Discontinued operations

    5.35

    0.03



    5.26

    0.01

      Diluted net income per share

    $                      7.14

    $                      2.26



    $                     14.51

    $                      7.92













    Shares used in computing per share amounts:











      Basic

    153,916

    151,972



    153,138

    152,146

      Diluted

    155,991

    154,845



    155,944

    155,195













    (1) Synopsys' fourth quarter of fiscal year 2024 and 2023 ended on November 2, 2024 and October 28, 2023, respectively. For presentation purposes, we refer to

    the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.





    SYNOPSYS, INC.





    Unaudited Consolidated Balance Sheets (1)





    (in thousands, except par value amounts)

















    October 31, 2024

    October 31, 2023





    ASSETS:









    Current assets:









      Cash and cash equivalents

    $               3,896,532

    $               1,433,966





      Short-term investments

    153,869

    151,639





              Total cash, cash equivalents and short-term investments

    4,050,401

    1,585,605





      Accounts receivable, net

    934,470

    856,660





      Inventories

    361,849

    325,590





      Prepaid and other current assets

    1,122,946

    548,115





      Current assets of discontinued operations

    —

    114,654





              Total current assets

    6,469,666

    3,430,624





    Property and equipment, net

    563,006

    549,837





    Operating lease right-of-use assets, net

    565,917

    559,923





    Goodwill

    3,448,850

    3,346,065





    Intangible assets, net

    195,164

    239,577





    Deferred income taxes

    1,247,258

    853,526





    Other long-term assets

    583,700

    444,820





    Long-term assets of discontinued operations

    —

    908,759





               Total assets

    $             13,073,561

    $             10,333,131















    LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND

    STOCKHOLDERS' EQUITY:









    Current liabilities:









      Accounts payable and accrued liabilities

    $               1,163,592

    $               1,059,914





      Operating lease liabilities

    94,791

    79,832





      Deferred revenue

    1,391,737

    1,559,461





      Current liabilities of discontinued operations

    —

    286,244





               Total current liabilities

    2,650,120

    2,985,451





    Long-term operating lease liabilities

    574,065

    579,686





    Long-term deferred revenue

    340,831

    150,827





    Long-term debt

    15,601

    18,078





    Other long-term liabilities

    469,738

    381,531





    Long-term liabilities of discontinued operations

    —

    33,257





               Total liabilities

    4,050,355

    4,148,830





    Redeemable non-controlling interest

    30,000

    31,043





    Stockholders' equity:









      Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

    —

    —





      Common stock, $0.01 par value: 400,000 shares authorized; 154,112 and

    152,053 shares outstanding, respectively

    1,541

    1,521





      Capital in excess of par value

    1,211,206

    1,276,152





      Retained earnings

    8,984,105

    6,741,699





      Treasury stock, at cost: 3,148 and 5,207 shares, respectively

    (1,025,770)

    (1,675,650)





      Accumulated other comprehensive income (loss)

    (180,380)

    (196,414)





               Total Synopsys stockholders' equity

    8,990,702

    6,147,308





    Non-controlling interest

    2,504

    5,950





               Total stockholders' equity

    8,993,206

    6,153,258





               Total liabilities, redeemable non-controlling interest and stockholders'

    equity

    $             13,073,561

    $             10,333,131















    (1) Synopsys' fiscal year 2024 and 2023 ended on November 2, 2024 and October 28, 2023, respectively. For presentation purposes, we

    refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter. 





















    SYNOPSYS, INC.

    Unaudited Consolidated Statements of Cash Flows (1)

    (in thousands)









    Twelve Months Ended



    2024

    2023

    CASH FLOWS FROM OPERATING ACTIVITIES:





    Net income

    $               2,235,810

    $               1,218,125

    Adjustments to reconcile net income to net cash provided by operating activities:





    Amortization and depreciation

    295,065

    247,120

    Reduction of operating lease right-of-use assets

    97,273

    97,705

    Amortization of capitalized costs to obtain revenue contracts

    73,587

    82,190

    Stock-based compensation

    692,316

    563,292

    Allowance for credit losses

    19,724

    19,932

    Gain on sale of strategic investments

    (55,077)

    —

    Gain on divestitures, net of transaction costs

    (868,830)

    —

    Amortization of bridge financing costs

    33,677

    —

    Deferred income taxes

    (407,649)

    (211,045)

    Other

    (1,295)

    13,295

    Net changes in operating assets and liabilities, net of effects from acquisitions and

    dispositions:





    Accounts receivable

    (103,460)

    (178,432)

    Inventories

    (51,449)

    (123,752)

    Prepaid and other current assets

    (410,432)

    (106,396)

    Other long-term assets

    (168,255)

    (100,618)

    Accounts payable and accrued liabilities

    187,564

    170,496

    Operating lease liabilities

    (96,966)

    (73,281)

    Income taxes

    (73,215)

    198,078

    Deferred revenue

    8,641

    (113,435)

    Net cash provided by operating activities

    1,407,029

    1,703,274







    CASH FLOWS FROM INVESTING ACTIVITIES:





    Proceeds from maturities and sales of short-term investments

    138,961

    130,435

    Purchases of short-term investments

    (136,821)

    (131,079)

    Proceeds from sales of strategic investments

    55,696

    8,492

    Purchases of strategic investments

    (1,293)

    (435)

    Purchases of property and equipment, net

    (123,161)

    (189,618)

    Acquisitions, net of cash acquired

    (156,947)

    (297,692)

    Proceeds from business divestiture, net of cash divested

    1,446,578

    —

    Capitalization of software development costs

    —

    (2,204)

    Net cash provided by (used in) investing activities

    1,223,013

    (482,101)







    CASH FLOWS FROM FINANCING ACTIVITIES:





    Repayment of debt

    (2,607)

    (2,603)

    Payment of bridge financing and term loan costs

    (72,265)

    —

    Issuances of common stock

    232,212

    252,986

    Payments for taxes related to net share settlement of equity awards

    (337,541)

    (241,408)

    Purchase of equity forward contract

    —

    (45,000)

    Purchases of treasury stock

    —

    (1,160,724)

    Other

    (1,096)

    (122)

    Net cash used in financing activities

    (181,297)

    (1,196,871)

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    8,797

    (2,979)

    Net change in cash, cash equivalents and restricted cash

    2,457,542

    21,323

    Cash, cash equivalents and restricted cash, beginning of year, including cash from

     discontinued operations

    1,441,187

    1,419,864

    Cash, cash equivalents and restricted cash, end of period, including cash from

    discontinued operations

    3,898,729

    1,441,187

    Less: Cash, cash equivalents and restricted cash from discontinued operations

    —

    4,947

    Cash, cash equivalents and restricted cash from continuing operations

    $               3,898,729

    $               1,436,240







    (1) Synopsys' fiscal year 2024 and 2023 ended on November 2, 2024 and October 28, 2023, respectively. For presentation purposes, we

     refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

    Synopsys provides segment information, namely revenue, adjusted segment operating income and adjusted segment operating margin, in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 280, Segment Reporting. Synopsys' chief operating decision maker ("CODM") is our Chief Executive Officer. In evaluating our business segments, the CODM considers the income and expenses that the CODM believes are directly related to those segments. The CODM does not allocate certain operating expenses managed at a consolidated level to our business segments and, as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table below. These unallocated expenses are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income from continuing operations:

    SYNOPSYS, INC.

    Business Segment Reporting (1)(2)(5)

    (in millions)













    Three Months Ended

    October 31, 2024

    Three Months Ended

    October 31, 2023

    Twelve Months Ended

    October 31, 2024

    Twelve Months Ended

    October 31, 2023



    Revenue by segment









    - Design Automation

    $                        1,118.2

    $                           953.7

    $                        4,221.1

    $                        3,775.3

    % of Total

    68.3 %

    65.0 %

    68.9 %

    71.0 %

    - Design IP

    $                           517.8

    $                           513.7

    $                        1,906.3

    $                        1,542.7

    % of Total

    31.7 %

    35.0 %

    31.1 %

    29.0 %











    Adjusted operating income by segment









    - Design Automation

    $                           413.3

    $                           311.1

    $                        1,631.9

    $                        1,413.9

    - Design IP

    $                           189.9

    $                           236.4

    $                           730.2

    $                           514.1











    Adjusted operating margin by segment









    - Design Automation

    37.0 %

    32.6 %

    38.7 %

    37.5 %

    - Design IP

    36.7 %

    46.0 %

    38.3 %

    33.3 %











    Total Adjusted Segment Operating Income Reconciliation (1)(2)(5)

    (in millions)













    Three Months Ended

    October 31, 2024

    Three Months Ended

    October 31, 2023

    Twelve Months Ended

    October 31, 2024

    Twelve Months Ended

    October 31, 2023



    GAAP total operating income – as reported

    $                           310.8

    $                           424.2

    $                        1,355.7

    $                        1,273.2

    Other expenses managed at consolidated level









    -Amortization of acquired intangible assets (3)

    70.9

    15.9

    124.2

    54.6

    -Stock-based compensation (3)

    165.4

    128.6

    657.9

    513.1

    -Non-qualified deferred compensation plan

    9.2

    (23.9)

    85.4

    20.2

    -Acquisition/divestiture related items (4)

    47.0

    4.0

    138.7

    13.8

    -Restructuring charges

    —

    (1.3)

    —

    53.1

    Total adjusted segment operating income

    $                           603.2

    $                           547.5

    $                        2,362.1

    $                        1,928.0











    (1) Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our

    business. Amounts may not foot due to rounding.

    (2) Synopsys' fourth quarter of fiscal year 2024 and 2023 ended on November 2, 2024 and October 28, 2023, respectively. For presentation purposes, we refer to

    the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter. 

    (3) The adjustment includes non-GAAP expenses attributable to non-controlling interest and redeemable non-controlling interest.

    (4) The adjustment excludes the amortization of bridge financing costs entered into in connection with the pending acquisition of Ansys, that was recorded in

     interest and other income (expense), net, in our unaudited condensed consolidated statements of income.

    (5) Presented on a continuing operations basis.

    GAAP to Non-GAAP Reconciliation

    Synopsys continues to provide all information required in accordance with GAAP but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. This press release includes non-GAAP earnings per diluted share, non-GAAP net income and non-GAAP tax rate for the periods presented. It also includes future estimates for non-GAAP expenses, non-GAAP interest and other income (expense), non-GAAP tax rate, non-GAAP earnings per diluted share and free cash flow. These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

    When possible, Synopsys provides a reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures. Synopsys is unable to provide a full reconciliation of certain first quarter and full fiscal year 2025 non-GAAP financial targets to the corresponding GAAP financial measures on a forward-looking basis because Synopsys believes that it would not be possible for it to have the required information necessary to quantitatively reconcile such measures with sufficient precision without unreasonable efforts due to, among other things, the potential variability and limited predictability of the excluded adjustment items necessary for a full reconciliation such as certain acquisition/divestiture related items, restructuring charges, tax deduction variability, changes in the fair value of non-qualified deferred compensation plan, and gains (losses) on the sale of strategic investments. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information. 

    Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, as superior to, or as a substitute for, financial information prepared in accordance with GAAP. These non-GAAP financial measures are meant to supplement, and be viewed in conjunction with, the corresponding GAAP financial measures. Synopsys' management believes presentation of non-GAAP financial measures, when shown in conjunction with the corresponding GAAP financial measures, provides useful information to investors allowing them to view financial and business trends relating to our financial condition and results of operations through the eyes of management. Synopsys' management evaluates and makes decisions about our business operations using both GAAP financial measures and non-GAAP financial measures to help facilitate internal comparisons to Synopsys' historical operating results and forecasted targets, planning and forecasting in subsequent periods and comparisons to competitors' operating results.

    The following are descriptions of the adjustments made to reconcile non-GAAP financial measures (other than free cash flow, which is defined in the footnote to the Financial Targets table above) to the most directly comparable GAAP financial measures:

    (i) Amortization of acquired intangible assets. We incur expenses from amortization of acquired intangible assets, which may include impairment charges from write-downs of acquired intangible assets. Acquired intangible assets include, among other things, core/developed technology, customer relationships, contract rights, trademarks and trade names, and other intangibles related to acquisitions. We amortize the intangible assets over their estimated useful lives. We do not enter into acquisitions on a predictable cycle. The amount of an acquisition's purchase price allocated to intangible assets and their estimated useful lives can vary significantly and are unique to each acquisition. From time to time, we incur impairment charges due to write-downs of acquired intangible assets. We believe that the presentation of non-GAAP financial measures that adjust for the amortization of intangible assets, including impairment charges, provides investors and others with a consistent basis for comparison across accounting periods. We also exclude this item because such expenses are non-cash in nature and we believe the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding our core operational performance and liquidity, and ability to invest in research and development and fund future acquisitions and capital expenditures.

    (ii) Stock-based compensation. Stock-based compensation expenses consist primarily of expenses related to restricted stock units, stock options, employee stock purchase rights and other stock awards, including such expenses associated with acquisitions. We exclude stock-based compensation expense from our non-GAAP financial measures primarily because it is not an expense that typically requires or will require cash settlement by us. Further, the expense for the fair value of the stock-based instruments we utilize may bear little resemblance to the actual value realized upon the vesting or future exercise of the related stock-based awards and, therefore, is not used by management to assess the core profitability of our business operations.

    (iii) Acquisition/divestiture related items. In connection with certain of our business combinations and/or divestitures, we incur significant expenses that we would not have otherwise incurred as part of our business operations. These expenses include, among other things, compensation expenses, professional fees and other direct expenses, concurrent restructuring activities and divestiture activities, including employee severance and other exit costs, bridge financing costs, costs related to integration activities, changes to the fair value of contingent consideration related to the acquired company, and amortization of the fair value difference of below-market value assets arising from arrangements entered into or acquired in conjunction with an acquisition. We also recognize the gains and losses from the mark-up of equity or cost method investments to fair value upon obtaining control through acquisition. We exclude these items because they are related to acquisitions and have no direct correlation to the core operation of our business. Further, because we do not acquire businesses on a predictable cycle and the terms of each transaction can vary significantly and are unique to each transaction, we believe it is useful to exclude such expenses when looking for a consistent basis for comparison across accounting periods.

    (iv) Restructuring charges. We initiate restructuring activities to align our costs to our operating plans and business strategies based on then-current economic conditions, and such activities have a specific and defined term. Restructuring costs generally include severance and other termination benefits related to voluntary retirement programs, involuntary headcount reductions and facilities closures. Such restructuring costs include elimination of operational redundancy, permanent reductions in workforce and facilities closures and, therefore, are not considered by us to be a part of the core operation of our business and are not used by management when assessing the core profitability and performance of our business operations.

    (v) Gains (losses) on the sale of strategic investments. We exclude gains and losses on the sale of equity investments in privately held companies because we do not believe they are reflective of our core business and operating results.

    (vi) Deferred compensation. We exclude changes in the fair value of our non-qualified deferred compensation plan because we do not use these to assess the core profitability of our business operations.

    (vii) Income tax effect of non-GAAP pre-tax adjustments. Excluding the income tax effect of non-GAAP pre-tax adjustments from the provision for income taxes assists investors in understanding the tax provision associated with those adjustments and the effect on net income. We utilize an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect our normal operations, and to more closely align our tax rate with our expected geographic earnings mix. This annual non-GAAP tax rate is based on an evaluation of our historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives. Based on these considerations, we have elected to adopt a non-GAAP tax rate of 16% for fiscal year 2025.

    INVESTOR CONTACT:

    Trey Campbell

    Synopsys, Inc.

    650-584-4289

    [email protected] 

    EDITORIAL CONTACT:

    Cara Walker

    Synopsys, Inc.

    650-584-5000

    [email protected]

    Synopsys (PRNewsfoto/Synopsys)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-fourth-quarter-and-fiscal-year-2024-302322901.html

    SOURCE Synopsys, Inc.

    Get the next $SNPS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNPS

    DatePrice TargetRatingAnalyst
    1/13/2025$600.00Buy
    Redburn Atlantic
    11/22/2024$570.00Equal Weight
    Wells Fargo
    11/12/2024$675.00Buy
    Loop Capital
    10/22/2024$650.00Outperform
    Mizuho
    10/15/2024$660.00Buy
    Berenberg
    4/4/2024$665.00Overweight
    Piper Sandler
    11/30/2023$500.00 → $660.00Buy
    Needham
    11/10/2023$600.00Overweight
    Morgan Stanley
    More analyst ratings

    $SNPS
    Leadership Updates

    Live Leadership Updates

    See more
    • Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

      The standalone application security company continues its mission to help organizations build trust in their software to support innovation and business transformation SANTA MONICA, Calif. and SAN FRANCISCO, Oct. 1, 2024 /PRNewswire/ -- Clearlake Capital Group ("Clearlake") and Francisco Partners announced today that they have completed their acquisition of the Synopsys Software Integrity Group, establishing the newly independent application security company as Black Duck Software, Inc. ("Black Duck"). The transaction with Synopsys, Inc. (NASDAQ:SNPS), which was first announced on May 6, 2024, is valued at up to $2.1 billion, including up to $475 million in cash payable upon Clearlake and Fr

      10/1/24 9:06:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

      The standalone application security company continues its mission to help organizations build trust in their software to support innovation and business transformation Clearlake Capital Group ("Clearlake") and Francisco Partners announced today that they have completed their acquisition of the Synopsys Software Integrity Group, establishing the newly independent application security company as Black Duck Software, Inc. ("Black Duck"). The transaction with Synopsys, Inc. (NASDAQ:SNPS), which was first announced on May 6, 2024, is valued at up to $2.1 billion, including up to $475 million in cash payable upon Clearlake and Francisco Partners achieving a specified rate of return in connection

      10/1/24 8:30:00 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SiMa.ai Secures Funds and Readies New Generative Edge AI Platform

      Oversubscribed $70M round led by Maverick Capital increases SiMa.ai's total amount raised to $270M; funding will speed release of next generation AI/ML chip to power multimodal generative AI at the edge SiMa.ai, the software-centric, embedded edge machine learning system-on-chip company, today announced it has raised an additional $70M of funding led by Maverick Capital, with participation from Point72 and Jericho, as well as existing investors Amplify Partners, Dell Technologies Capital, Lip-Bu Tan and others. SiMa.ai will utilize the $270M raised to date to continue meeting customer demand for edge AI/ML with its first-generation Machine Learning System-on-Chip (MLSoC) while acceleratin

      4/4/24 9:00:00 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Synopsys Announces Earnings Release Date For Second Quarter Fiscal Year 2025

      SUNNYVALE, Calif., May 7, 2025  /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the second quarter fiscal year 2025 on Wednesday, May 28, 2025, after market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on this sit

      5/7/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys and Intel Foundry Propel Angstrom-Scale Chip Designs on Intel 18A and Intel 18A-P Technologies

      Synopsys Production-Ready EDA Flows and Broadest IP Portfolio Deliver Leading PPA for Intel Foundry's Advanced Processes and Packaging Technologies Highlights Production-ready Synopsys digital and analog EDA flows for Intel 18A and Intel 18A-P technologies pave the way for broad adoption and accelerate development of high-performance designs; engaged in early design technology co-optimization for Intel 14A-EOptimized EDA reference flow with a unified exploration-to-signoff platform accelerates 2.5D/3D multi-die designs for Intel's EMIB-T advanced packaging technologyBroadest portfolio of high-performance and low-power IP for Intel 18A and expanded Synopsys IP support for Intel 18A-P offers

      4/29/25 12:00:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys and TSMC Usher In Angstrom-Scale Designs with Certified EDA Flows on Advanced TSMC A16 and N2P Processes

      AI-Driven Digital and Analog Flows, Multi-Die Innovations, and Broad IP Portfolio Deliver Unmatched Performance, Power and Area Advantages Highlights Digital and analog design flows on TSMC A16™ and N2P deliver optimized performance and rapid analog design migration, enabled by Synopsys.aiEarly collaboration on TSMC A14 process underway for Synopsys EDA flows developmentCollaboration on 3Dblox and TSMC's CoWoS® technologies for 5.5x reticle size packages, speeds integration of 3D stacked dies in next-generation AI chipsBroad portfolio of Synopsys Foundation and Interface IP provides the lowest power on TSMC's N2/N2P processesIndustry's most complete IP solutions for leading-edge standards, i

      4/23/25 4:00:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Synopsys Inc.

      SCHEDULE 13G - SYNOPSYS INC (0000883241) (Subject)

      5/13/25 11:44:13 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

      8-K - SYNOPSYS INC (0000883241) (Filer)

      3/17/25 4:30:50 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - SYNOPSYS INC (0000883241) (Filer)

      3/5/25 5:18:49 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $SNPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Redburn Atlantic initiated coverage on Synopsys with a new price target

      Redburn Atlantic initiated coverage of Synopsys with a rating of Buy and set a new price target of $600.00

      1/13/25 8:42:39 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Wells Fargo initiated coverage on Synopsys with a new price target

      Wells Fargo initiated coverage of Synopsys with a rating of Equal Weight and set a new price target of $570.00

      11/22/24 8:02:35 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Loop Capital initiated coverage on Synopsys with a new price target

      Loop Capital initiated coverage of Synopsys with a rating of Buy and set a new price target of $675.00

      11/12/24 7:51:10 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Director Schwarz John was granted 491 shares, increasing direct ownership by 4% to 12,787 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:22:48 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Director Sargent Jeannine P was granted 491 shares, increasing direct ownership by 24% to 2,544 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:22:16 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Director Painter Robert G was granted 491 shares, increasing direct ownership by 34% to 1,941 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      4/14/25 4:21:38 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Financials

    Live finance-specific insights

    See more
    • Synopsys Announces Earnings Release Date For Second Quarter Fiscal Year 2025

      SUNNYVALE, Calif., May 7, 2025  /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the second quarter fiscal year 2025 on Wednesday, May 28, 2025, after market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on this sit

      5/7/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Posts Financial Results for First Quarter Fiscal Year 2025

      Results Summary Quarterly revenue of $1.455 billion, exceeding midpoint of guidance.Quarterly GAAP earnings per diluted share of $1.89; non-GAAP earnings per diluted share of $3.03, exceeding guidance.Reaffirming full-year 2025 guidance.SUNNYVALE, Calif., Feb. 26, 2025 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its first quarter of fiscal year 2025. Revenue for the first quarter of fiscal year 2025 was $1.455 billion, compared to $1.511 billion for the first quarter of fiscal year 2024. "In Q1, Synopsys' relentless focus on execution and innovatio

      2/26/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • Synopsys Announces Earnings Release Date For First Quarter Fiscal Year 2025

      SUNNYVALE, Calif., Jan. 27, 2025 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the first quarter fiscal year 2025 on Wednesday, February 26, 2025, after the market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on

      1/27/25 4:05:00 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Casper Marc N bought $439,087 worth of shares (750 units at $585.45), increasing direct ownership by 76% to 1,736 units (SEC Form 4)

      4 - SYNOPSYS INC (0000883241) (Issuer)

      3/27/24 11:12:13 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology

    $SNPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/14/23 12:37:55 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/9/23 11:32:50 AM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Synopsys Inc. (Amendment)

      SC 13G/A - SYNOPSYS INC (0000883241) (Subject)

      2/14/22 2:34:19 PM ET
      $SNPS
      Computer Software: Prepackaged Software
      Technology